Skip to content
Screener

Harrow HROW Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$00.0%
AbbVie logo
AbbVieABBV
Schering-Plough logo
Schering-PloughSGP
PTH
Pelthos TherapeuticsPTHS
TOI
TOITOI

Other financials

Income statement

See full
Revenue$70.7M+10.9%
Gross profit$50.4M+6.0%
Operating income-$11.0M-196%
Net income-$17.3M-446%
EPS (diluted)-$0.46-454%

Balance sheet

See full
Cash & equivalents$83.9M+58.4%
Total debt$308.4M-32.0%
Total equity$15.2M-69.4%
Total assets$416.8M+20.8%

Cash flow

See full
Operating cash flow-$9.8M
CapEx$491.0K+196%
Free cash flow-$10.2M

Valuation

See full
Market cap$1.51B+22.5%
Enterprise value$1.73B+6.3%
P/S5.5×+0.1×

Profitability

See full
Gross margin73.3%-1.3pp
Operating margin-1%-7.3pp
Net margin-19.8%+18.0pp
FCF margin1.8%+1.3pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity20.3×+11.2×
Current ratio2.2×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Harrow’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055271
Line itemJune 30,2026December 31,2025
TOTAL LIABILITIES401,971,000347,391,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 50,000,000 shares authorized, 37,484,233 and 37,229,159 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively37,00037,000
Additional paid-in capital216,559,000208,933,000
Accumulated deficit(201,396,000)(156,524,000)
TOTAL HARROW, INC. STOCKHOLDERS’ EQUITY15,200,00052,446,000
Noncontrolling interests(355,000)(355,000)

Item 1. Financial Statements

FAQ

What is Harrow's common stock, par value (in dollars per share)?
Harrow (HROW) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
How has Harrow's common stock, par value (in dollars per share) changed year-over-year?
Harrow's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for Harrow's common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), Harrow's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
What does common stock, par value (in dollars per share) mean?
Common stock, par value (in dollars per share)

Ask your AI about Harrow's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude